Monza, Italy

Rolando Chiste


Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 1989-1997

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Rolando Chiste

Introduction

Rolando Chiste is a notable inventor based in Monza, Italy. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on optically active derivatives. With a total of 7 patents to his name, Chiste's inventions reflect his dedication to advancing medical science.

Latest Patents

Chiste's latest patents include the development of optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid. These derivatives and their pharmaceutically acceptable salts exhibit antagonistic activity towards cholecystokinin. The formula for these compounds includes specific groups such as 2-naphthyl, 3,4-dichlorophenyl, and 3,4-dimethylphenyl, with substituents on the central chiral group having the R (rectus) conformation. This innovative work has the potential to impact therapeutic approaches significantly.

Career Highlights

Throughout his career, Rolando Chiste has worked with esteemed organizations, including Rotta Research Laboratorium S.p.a. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Chiste has collaborated with notable colleagues such as Francesco Makovec and Walter Peris. These partnerships have fostered an environment of innovation and creativity, leading to advancements in their respective fields.

Conclusion

Rolando Chiste's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…